fda compounding semaglutide update today Troubling Findings in Study of GLP-1 Compounders Compounding pharmacies to halt semaglutide

Plasma levels of GHK have been documented to decline from approximately 200 ng/mL at age 20 to roughly 80 ng/mL at age 60, a 60% drop [1]

Results May Vary: Individual results will vary based on factors including age, baseline weight, metabolic health, genetic factors, consistency of medication use, dietary choices, physical activity levels, sleep quality, stress levels, current medications, and other individual variables

GLP-1 Receptor Agonists: A New Treatment in Parkinsons Disease

It helps reduce the accumulation of triglycerides in the blood, thereby lowering the risk of cardiovascular diseases such as atherosclerosis